Delivery Order SPE2DB20D2104-SPE2DB22FS83T
Award Date
5/25/22
Potential Completion Date
5/26/22
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded under a pre-existing Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,564,965,546 units of the pharmaceutical product Clindamycin 300 mg/50 ml-NS 50 ml, with a ceiling value of $1,182.48. The order has a firm fixed price and is set to be completed by June 24, 2024. Amerisourcebergen, a major supplier of pharmaceutical and medical products to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract covers the supply of 4,567,211,507 units of Clindamycin 150mg medication, with a ceiling value of $1,230.75. The delivery order has a firm fixed price and is not associated with a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4562692183 CLINDAMYCIN 900 MG/50 ML-D5W 50ML, with a ceiling value of $2,616.04 and a period of performance through November 3, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which has a Ceiling Value of $6,050.85, is for the delivery of CLINDAMYCIN 600 MG/50 ML-D5W 50ML pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an Ultimate Completion Date of January 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, valued at $1,154.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clindamycin 900 mg/50 ml-D5W 50 ml, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of a pharmaceutical product, Clindamycin PH 1% Solution 30ML. The contract has a ceiling value of $3,091.30 and an ultimate completion date of March 18, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,250.04 firm fixed price delivery order is for the supply of 4563412457 - CLINDAMYCIN 900 MG/50 ML-D5W 50ML, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award is for the delivery of Clindamycin 900 mg/50 ml-D5W 50 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,218.38 and was awarded to Amerisourcebergen Drug Corp, a division of the parent company Cencora, Inc. The contract is a delivery order with a firm-fixed price pricing type and has an ultimate completion date of March 20, 2023. This contract does not have a set-aside designation. Amerisourcebergen Drug Corp...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,709.23, is for the delivery of CLINDAMYCIN 600 MG/50 ML-D5W 50ML, a pharmaceutical product, to support military healthcare programs. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,246.55 firm-fixed-price contract is for the supply of 4567088182 CLINDAMYCIN 600 MG/50 ML-D5W 50ML, with a performance period through January 30, 2025. This delivery order is issued under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...